MENU

jlca2025

Program

State of the Art Lecture

State of the Art Lecture 1

July 12 Sat  8:45-9:15/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Sheng-Long Ye(Fudan University, Shanghai)
SA-1Precision Diagnosis and Treatment of Hepatocellular Carcinoma
Speaker
Jia Fan(Fudan University, Shanghai)

State of the Art Lecture 2

July 12 Sat  13:30-14:00/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Norihiro Kokudo(National Center for Global Health and Medicine, Tokyo)
SA-2 A Global Call to Action to Reduce the Burden of Liver Cancer
Speaker
Jian Zhou(Fudan University, Shanghai)

State of the Art Lecture 3

July 12 Sat  15:20-15:50/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Jinsil Seong(Yonsei Univ., Seoul)
SA-3Hepatocellular carcinoma: What is the big picture? And are we seeing it?
Speaker
Ghassan K Abou-Alfa(Memorial Sloan Kettering Cancer Center, New York)

State of the Art Lecture 4

July 13 Sun  10:15-10:45/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Masatoshi Kudo(Kindai University, Osaka)
SA-4Current status and Future perspectives of multidisciplinary treatment for advanced HCC in Kobe University
Speaker
Takumi Fukumoto(Kobe University, Kobe)

State of the Art Lecture 5

July 13 Sun  14:45-15:15/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Ann-Lii Cheng(National Taiwan Univ., Taipei)
SA-5Navigating the optimal management of HCC
Speaker
Kwang-Hyub Han(Yonsei Univ., Seoul)

State of the Art Lecture 6

July 13 Sun  14:45-15:15/ROOM B  Main Building, B1, Hall Kairaku 3

Chair
Chiun Hsu(National Taiwan Univ., Taipei)
SA-6Towards Multi-Omics Spatial Analysis to Reveal Cancer Heterogeneity
Speaker
Yutaka Suzuki(The University of Tokyo, Kashiwa)

Session 1

Session 1a. Epidemiology and Medical Circumstance for HCC in Asian-Pacific region

July 12 Sat  9:15-10:30/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Thomas Yau(The Univ. of Hong Kong, Hong Kong)
Kyung-Suk Suh(Seoul National Univ., Seoul)
Commentator
Kazuyoshi Ohkawa(Osaka International Cancer Institute, Osaka)
Hidekatsu Kuroda(Iwate Medical University, Iwate)
S1a-1Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization before Major Hepatectomy for Hepatocellular Carcinoma to Achieve Hypertrophy Liver Remnant
Speaker
Lian-Xin Liu(University of Science and Technology of China, Anhui)
S1a-2Epidemiology of Liver Cancer in the Pacific Region
Speaker
Linda Wong(Univ. of Hawaii, Honolulu)
S1a-3Management of Hepatocellular Carcinoma in Taiwan ~ the changed and unchanged over the past two decades
Speaker
Chih-Hung Hsu(National Taiwan Univ., Taipei)
S1a-4Changes in Epidemiology and Management of Hepatocellular Carcinoma in South Korea
Speaker
Joong Won Park(National Cancer Center, Goyang)
S1a-5Epidemiology and Medical Circumstances of HCC in Japan
Speaker
Masayuki Kurosaki(Japanese Red Cross Musashino Hospital, Tokyo)

Session 1b. Epidemiology and Basic Science /Translational Research in CCA

July 12 Sat  9:15-10:30/ROOM B  Main Building, B1, Hall Kairaku 3

Chair
Stephen Chan(The Chinese University of Hong Kong, Hong Kong)
Yoon Jun Kim(Seoul National Univ., Seoul)
Commentator
Hiroshi Imaoka(National Cancer Center Hospital East, Kashiwa)
Takeshi Terashima(Kanazawa University, Kanazawa)
S1b-1Epidemiology
Speaker
Chigusa Morizane(National Cancer Center Hospital, Tokyo)
S1b-2Cholangiocarcinoma in the Spectrum of Primary Liver Cancers: Diagnostic and Therapeutic Insights from Pathology
Speaker
Mina Komuta(International University of Health and Welfare, School of Medicine, Narita Hospital, Chiba)
S1b-3Gene fusions generate potential therapeutic targets for iCCA
Speaker
Qiang Gao(Zhongshan Hospital, Fudan University, Shanghai)
S1b-4Concordance of Circulating Tumor DNA and Tissue Genomic Profiling in Advanced Biliary Tract Cancer
Speaker
Hong Jae Chon(CHA University, Seongnam)

Session 2

Session 2a. Molecular Pathogenesis and Pathology in HCC

July 12 Sat  10:45-12:20/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Michiie Sakamoto(International University of Health and Welfare, Tokyo)
Lian-Xin Liu(University of Science and Technology of China, Anhui)
Commentator
Shinji Tanaka(Institute of Science Tokyo, Tokyo)
Jun Akiba(Kurume University, Kurume)
S2a-1Update on the Molecular-Pathological Features of HCC
Speaker
Young Nyun Park(Yonsei Univ., Seoul)
S2a-2Immune microenvironment in HCC
Speaker
Yosuke Togashi(Okayama University, Okayama)
S2a-3Target Discovery in HCC
Speaker
Irene Ng(The Univ. of Hong Kong, Hong Kong)
S2a-4Delineating the Cellular Ecosystem of Hepatocellular Carcinoma with Microvascular Invasion through Immune-Radiomics Analysis
Speaker
Ying-Hong Shi(Fudan University, Shanghai)

Session 2b. Locoregional Therapy for CCA

July 12 Sat  10:45-12:20/ROOM B  Main Building, B1, Hall Kairaku 3

Chair
Su Pin Choo(National Cancer Centre Singapore, Singapore)
Changhoon Yoo(Univ. of Ulsan, Seoul)
Commentator
Michiaki Unno(Tohoku University, Sendai)
Atsushi Nanashima(Miyazaki University, Miyazaki)
S2b-1Current status and challengess in surgical management of intrahepatic cholangiocarcinoma
Speaker
Masayuki Otsuka(Chiba University, Chiba)
S2b-2Surgical management of cholangiocarcinoma
Speaker
Tan To Cheung(The Univ. of Hong Kong, Hong Kong)
S2b-3Radiotherapy for intrahepatic cholangiocarcinoma in the era of immunotherapy
Speaker
Zhao-Chong Zeng(Fudan University, Shanghai)
S2b-4Hepatic artery infusion chemotherapy for IHC
Speaker
William R. Jarnagin(Memorial Sloan Kettering Cancer Center, New York)

Session 3

Session 3a. Surgery and Liver Transplant for HCC

July 12 Sat  14:00-15:15/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Pierce Chow(National Cancer Centre Singapore, Singapore)
Zhao-Chong Zeng(Fudan University, Shanghai)
Commentator
Susumu Eguchi(Nagasaki University, Nagasaki)
Tomoharu Yoshizumi(Kyushu University, Fukuoka)
S3a-1Surgical resection combined with systemic therapy for advanced hepatocellular carcinoma
Speaker
Kiyoshi Hasegawa(Tokyo University , Tokyo)
S3a-2State-of-the-Art Surgery for Hepatocellular Carcinoma: Surgeon Scientist’s Viewpoint
Speaker
Ming Kuang(Sun Yat-sen University, Guangzhou)
S3a-3New Trends in Liver transplant for HCC in the US
Speaker
Linda Wong(Univ. of Hawaii, Honolulu)
S3a-4Conversion therapy for advanced hepatocellular carcinoma to liver resection or transplantation using a combination of systemic and loco-reginal treatments
Speaker
Ying-Hong Shi(Fudan University, Shanghai)

Session 3b. Systemic Therapy for CCA

July 12 Sat  14:00-15:15/ROOM B  Main Building, B1, Hall Kairaku 3

Chair
Andrew Zhu(Jiahui International cancer center, Shanghai)
Chih-Hung Hsu(National Taiwan Univ., Taipei)
Commentator
Masafumi Ikeda(National Cancer Center Hospital East, Kashiwa)
Masashi Kanai(Kansai Medical University Hospital, Osaka)
S3b-1Adjyuvant chemotherapy for biliary tract cancer
Speaker
Tomoki Ebata(Nagoya University, Nagoya)
S3b-2Systemic Therapy for Intrahepatic Cholangiocarcinoma: First-line
Speaker
Li-Tzong Chen(National Institute of Cancer Research, National Health Research Institutes (NHRI), Tainan)
S3b-3Recent Updates for Second-Line Therapy in Advanced Biliary Tract Cancer (BTC)
Speaker
Changhoon Yoo(Univ. of Ulsan, Seoul)
S3b-4Systemic therapy for CCA; Ongoing novel clinical trials
Speaker
Do-Youn Oh(Seoul National Univ., Seoul)

Session 4

Session 4a. Locoregional Therapy for HCC

July 12 Sat  17:10-18:30/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Min-Ke He(Sun Yat-sen University Cancer Center, Guangzhou)
Do Young Kim(Yonsei Univ., Seoul)
Commentator
Kengo Yoshimitsu(Fukuoka University, Fukuoka)
Takeshi Terashima(Kanazawa University, Kanazawa)
S4a-1Latest Topics of Ablation Thrapy
Speaker
Ryosuke Tateishi(Tokyo University, Tokyo)
S4a-2Latest Topics of TACE/TARE
Speaker
Yoon Jun Kim(Seoul National Univ., Seoul)
S4a-3FOLFOX HAIC:The New Regimen of Hepatic Arterial Infusion Chemotherapy for Large Hepatocellular Carcinoma
Speaker
Ming Shi(Sun Yat-sen University Cancer Center, Guangzhou)
S4a-4Recent hot topics in radiation therapy; Clinical potential of immunomodulatory effect of radiation by the dose level
Speaker
Jinsil Seong(Yonsei Univ., Seoul)

Session 4b. Rare Liver Tumors

July 12 Sat  17:10-18:30/ROOM B  Main Building, B1, Hall Kairaku 3

Chair
Irene Ng(The Univ. of Hong Kong, Hong Kong)
Young Nyun Park(Yonsei Univ., Seoul)
Commentator
Takuji Okusaka(National Cancer Center Hospital, Tokyo)
Shinichi Aishima(Kyushu University, Fukuoka)
S4b-1Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Systemic Treatment
Speaker
Tomoyuki Satake(National Cancer Center Hospital East, kashiwa)
S4b-2Fibrolamellar carcinoma
Speaker
Ghassan K Abou-Alfa(Memorial Sloan Kettering Cancer Center, New York)
S4b-3Comprehensive Clinicopathological and Whole-Exome Analysis of Cholangiolocarcinoma
Speaker
Takamichi Ishii(Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto)
S4b-4Epithelioid hemangioendothelioma, an ultra-rare soft tissue sarcoma: recent topics of interest
Speaker
Satoshi Shiba(National Cancer Center, Tokyo)
S4b-5Hepatoblastoma and Pediatric Liver Tumors: Distinct Biology, Global Collaboration, and Evolving Strategies
Speaker
Tomoro Hishiki(Department of Pediatric Surgery, Chiba University, Chiba)

Session 5

Session 5a. Systemic Therapy for Early-stage HCC

July 13 Sun  8:30-10:00/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Ming Kuang(Sun Yat-sen University, Guangzhou)
Qiang Gao(Zhongshan Hospital, Fudan University, Shanghai)
Commentator
Akinobu Taketomi(Hokkaido University, Sapporo)
Makoto Ueno(Kanagawa Cancer Center Research Institute, Kanagawa)
S5a-1Adjuvant Therapy after Loco-regional Treatment in Hepatocellular Carcinoma
Speaker
Pierce Chow(National Cancer Centre Singapore, Singapore)
S5a-2Evolving Landscape and Evidence for Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma
Speaker
Wei Zhang(Tongji Medical College, Wuhan)
S5a-3Treatment Strategy for Borderline Resectable Hepatocellular Carcinoma
Speaker
Tomoaki Yoh(Kyoto University, Kyoto)
S5a-4Perioperative Treatment of Liver Transplant
Speaker
Kyung-Suk Suh(Seoul National Univ., Seoul)
S5a-5The Potential Role of Systemic Therapy in Early-Stage Hepatocellular Carcinoma: A Special Clinical Consideration
Speaker
Kaoru Tsuchiya(Japanese Red Cross Musashino Hospital, Tokyo)

Session 5b. Debate session

July 13 Sun  8:30-10:00/ROOM B  Main Building, B1, Hall Kairaku 3

Chair
Tan To Cheung(The Univ. of Hong Kong, Hong Kong)
Yi-Hsiang Huang(National Yang Ming Chiao Tung University, Taipei)
Commentator
Kazuomi Ueshima(Kindai University, Osaka)
Shinji Itoh(Kyushu University, Fukuoka)
S5b-1Treatment strategy combining ICI chemotherapy and surgery for advanced hepatocellular carcinoma
Speaker
Masaki Kaibori(Kansai Medical University, Osaka)
S5b-2Borderline resectable HCC: Neoadjuvant therapy
Speaker
Etsuro Hatano(Kyoto University, Kyoto)
S5b-3Conversion possible: resection
Speaker
Junichi Shindoh(Toranomon Hospital , Tokyo)
S5b-4Conversion possible: Continue systemic therapy
Speaker
Satoshi Kobayashi(Kanagawa Cancer Center, Yokohama)
S5b-5Some up-to-7 out hepatocellular carcinomas can be cured by transarterial chemoembolization alone
Speaker
Shiro Miyayama(Fukuiken Saiseikai Hospital, Fukui)
S5b-6Case 3. Intermediate HCC: TACE+Systemic therapy
Speaker
Stephen Chan(The Chinese University of Hong Kong, Hong Kong)
S5b-7Case 4. Advanced stage HCC with Vp4: Systemic therapy
Speaker
Yutaka Yasui(Musashino Red Cross Hospital, Tokyo)
S5b-8Advanced stage HCC with Vp4: FOLFOX-HAIC
Speaker
Min-Ke He(Sun Yat-sen University Cancer Center, Guangzhou)

Session 6

Session 6a. Systemic Therapy for Intermediate-stage HCC

July 13 Sun  10:45-12:15/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Joong Won Park(National Cancer Center, Goyang)
Ming Shi(Sun Yat-sen University Cancer Center, Guangzhou)
Commentator
Takamichi Murakami(Kobe University, Kobe)
Teiji Kuzuya(Fujita Health University School of Medicine, Nagoya)
S6a-1TACE refractoriness and TACE unsuitability
Speaker
Do Young Kim(Yonsei Univ., Seoul)
S6a-2Is systemic therapy alone feasible for intermediate-stage HCC?
Speaker
Yi-Hsiang Huang(National Yang Ming Chiao Tung University, Taipei)
S6a-3Combination therapy of TACE with Systemic therapy
Speaker
Masatoshi Kudo(Kindai University, Osaka)
S6a-4Utilizing the conversion concept based on disease status following systemic chemotherapy for hepatocellular carcinoma
Speaker
Shohei Komatsu(Kobe University, Kobe)
S6a-5Optimizing Immunotherapy: Radiologist’s Perspective
Speaker
Eisuke Ueshima(Kobe University, Kobe)

Session 6b. Hepatology in HCC Management

July 13 Sun  10:45-12:15/ROOM B  Main Building, B1, Hall Kairaku 3

Chair
Andrew Zhu(Jiahui International cancer center, Shanghai)
Ryosuke Tateishi(Tokyo University, Tokyo)
Commentator
Masato Ozaka(Cancer Institute Hospital of JFCR, Tokyo)
Tomokazu Kawaoka(Hiroshima University , Hiroshima)
S6b-1Clinical Feasibility of Circulating Tumor DNA in Advanced Hepatocellular Carcinoma
Speaker
Hong Jae Chon(CHA University, Seongnam)
S6b-2Novel Biomarkers on Immunotherapy Treatment for Unresectable HCC
Speaker
Takahiro Kodama(Osaka University, Osaka)
S6b-3Gut-liver axis-mediated mechanism of liver cancer development: gut microbial components alter liver tumor microenvironment
Speaker
Naoko Ohtani(Osaka Metropolitan University, Osaka)
S6b-4Factors Influencing Immune Checkpoint Inhibitor Efficacy
Speaker
Taro Shibuki(National Cancer Center Hospital East, Kashiwa)
S6b-5Disparities between viral versus metabolic HCC
Speaker
Ming-Lung Yu(Kaohsiung Medical University, Kaohsiung)

Session 7

Session 7a. Systemic Therapy for Advanced-stage HCC

July 13 Sun  13:15-14:45/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Kwang-Hyub Han(Yonsei Univ., Seoul)
Sheng-Long Ye(Fudan University, Shanghai)
Commentator
Atsushi Hiraoka(Ehime Prefectural Central Hospital, Matsuyama)
Toshifumi Tada(Kobe University, Kobe)
S7a-1First-Line Therapy
Speaker
Thomas Yau(The Univ. of Hong Kong, Hong Kong)
S7a-2Second-line therapy for unresectable hepatocellular carcinoma (HCC)
Speaker
Chiun Hsu(National Taiwan Univ., Taipei)
S7a-3Evolving strategies for late-line treatment in advanced hepatocellular carcinoma
Speaker
Sadahisa Ogasawara(Chiba University, Chiba)
S7a-4Locoregional Treatment in Advanced HCC: Moving Toward a New Necessity
Speaker
Hyunchul Rhim(Samsung Medical Center, Changwon)
S7a-5Trends in Drug Development for HCC
Speaker
Ann-Lii Cheng(National Taiwan Univ., Taipei)

Session 7b. Novel strategies for CCA: Others

July 13 Sun  13:15-14:45/ROOM B  Main Building, B1, Hall Kairaku 3

Chair
Do-Youn Oh(Seoul National Univ., Seoul)
Masafumi Ikeda(National Cancer Center Hospital East, Kashiwa)
Commentator
Hiroshi Imaoka(National Cancer Center Hospital East, Kashiwa)
Masashi Kanai(Kansai Medical University Hospital, Osaka)
S7b-1Transplantation for Advanced IHC
Speaker
William R. Jarnagin(Memorial Sloan Kettering Cancer Center, New York)
S7b-2Noval Targets of Cholangiocarcinoma
Speaker
Ying-Chun Shen(National Taiwan University Cancer Center, Taipei)
S7b-3Molecular Heterogeneity in CCA and predictive biomarkers
Speaker
Su Pin Choo(National Cancer Centre Singapore, Singapore)
S7b-4Immune Landscape of Intrahepatic Cholangiocarcinoma and its Clinical Implication
Speaker
Naoshi Nishida(Kindai University, Osaka)
S7b-5Optimal Dose of Immune Checkpoint Inhibitor -Flat-, Body-weight based-, or Low-dose?
Speaker
Li-Tzong Chen(National Institute of Cancer Research, National Health Research Institutes (NHRI), Tainan)

Session 8

Session 8a:Presentations of Selected Abstracts I

July 13 Sun  15:30-16:15/ROOM A  Main Building, B1, Hall Kairaku 1+2

Chair
Jian Zhou(Fudan University, Shanghai)
Masayuki Kurosaki(Japanese Red Cross Musashino Hospital, Tokyo)
Commentator
Kenji Fukushima(Kobe University, Kobe)
Takahiro Kodama(Osaka University, Osaka)
S8a-1Prognostic and predictive value of lymphocyte-to-monocyte transition in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab
Presenter
Masaki Omori(Kobe University, Kobe)
S8a-2The usefulness of the non-invasive scoring systems for the hepatocarcinogenesis in patients with MASLD/MASH
Presenter
Takashi Nishimura(Hyogo Medical University, Hyogo)
S8a-3Tumor Budding Predicts Poor Survival in Hepatocellular Carcinoma Patients Treated with Neoadjuvant/Conversion Therapy: A Cohort Study Using ITBCC Criteria
Presenter
Pu-Wen Shen(Zhongshan Hospital, Fudan University, Shanghai)

Session 8b:Presentations of Selected Abstracts II

July 13 Sun  15:30-16:15/ROOM B  Main Building, B1, Hall Kairaku 3

Chair
Makoto Ueno(Kanagawa Cancer Center Research Institute, Kanagawa)
Ming-Lung Yu(Kaohsiung Medical University, Kaohsiung)
Commentator
Masato Ozaka(Cancer Institute Hospital of JFCR, Tokyo)
Satoshi Shimizu(Saitama Cancer Center, Saitama)
S8b-1Dose-Response Association Between Body Mass Index and the Risk of Cholangiocarcinoma
Presenter
Joo-Hyun Park(Korea University Ansan Hospital, Ansan)
S8b-2Survival Outcomes of Transarterial Treatment versus Systemic Therapy as Initial Treatment for Hepatocellular Carcinoma with Extrahepatic Metastasis
Presenter
Jaejun Lee(Catholic University of Korea, Seoul)
S8b-3Reconstructing Exosomal Biomechanical Signatures from RNA Profiles to Predict Hepatocellular Carcinoma Progression: A Deep Learning-Based Approach
Presenter
Rifaldy Fajar(The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Foundation)
  • jlca61
  • OFFICIAL TRAVEL GUIDE OF KOBE
  • KOBE CONVENTION BUREAU
  • エーザイ
  • Roche
  • アストラゼネガ
  • キャノン